Search Results - Maute, Luise

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Feasibility of sequential use of sunitinib and temsirolimus in advanced renal cell carcinoma

    Feasibility of sequential use of sunitinib and temsirolimus in advanced renal cell carcinoma by Gerullis, Holger, Bergmann, Lothar, Maute, Luise, Ecke, Thorsten Holger, Eimer, Christoph, Bagner, Jens Willem, Otto, Thomas

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Initial experience with 18F-fluoroethylcholine PET/CT in staging and monitoring therapy response of advanced renal cell carcinoma

    Initial experience with 18F-fluoroethylcholine PET/CT in staging and monitoring therapy response of advanced renal cell carcinoma by Middendorp, Marcus, Maute, Luise, Sauter, Bruno, Vogl, Thomas J., Grünwald, Frank

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    The dual PI3K/mTOR inhibitor NVP-BGT226 induces cell cycle arrest and regulates Survivin gene expression in human pancreatic cancer cell lines

    The dual PI3K/mTOR inhibitor NVP-BGT226 induces cell cycle arrest and regulates Survivin gene expression in human pancreatic cancer cell lines by Glienke, Wolfgang, Maute, Luise, Wicht, Johannes, Bergmann, Lothar

    Published in Tumor biology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Wilms’ tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells

    Wilms’ tumour gene 1 (WT1) as a target in curcumin treatment of pancreatic cancer cells by Glienke, Wolfgang, Maute, Luise, Wicht, Johannes, Bergmann, Lothar

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  5. 5
    Therapy of mRCC beyond mTOR-inhibition in clinical practice: results of a retrospective analysis

    Therapy of mRCC beyond mTOR-inhibition in clinical practice: results of a retrospective analysis by Maute, Luise, Grünwald, Viktor, Weikert, Steffen, Kube, Ulrich, Gauler, Thomas, Kahl, Christoph, Burkholder, Iris, Bergmann, Lothar

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Experiences and practical conclusions concerning temsirolimus use and adverse event management in advanced renal cell carcinoma within a compassionate use program in Germany

    Experiences and practical conclusions concerning temsirolimus use and adverse event management in advanced renal cell carcinoma within a compassionate use program in Germany by Gerullis, Holger, Bergmann, Lothar, Maute, Luise, Eimer, Christoph, Otto, Thomas

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Initial experience with super(18)F-fluoroethylcholine PET/CT in staging and monitoring therapy response of advanced renal cell carcinoma

    Initial experience with super(18)F-fluoroethylcholine PET/CT in staging and monitoring therapy response of advanced renal cell carcinoma by Middendorp, Marcus, Maute, Luise, Sauter, Bruno, Vogl, Thomas J, Gruenwald, Frank

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: